APA引文

F, M., C, M., S, C., F, F., L, P., T, B., . . . M, M. (2024, January). Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study. Clinical, Cosmetic and Investigational Dermatology.

Chicago Style (17th ed.) Citation

F, Martora, Marasca C, Cacciapuoti S, Fariello F, Potestio L, Battista T, Scalvenzi M, and Megna M. "Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study." Clinical, Cosmetic and Investigational Dermatology Jan. 2024.

MLA引文

F, Martora, et al. "Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study." Clinical, Cosmetic and Investigational Dermatology, Jan. 2024.